MX378402B - Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno. - Google Patents

Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno.

Info

Publication number
MX378402B
MX378402B MX2018002176A MX2018002176A MX378402B MX 378402 B MX378402 B MX 378402B MX 2018002176 A MX2018002176 A MX 2018002176A MX 2018002176 A MX2018002176 A MX 2018002176A MX 378402 B MX378402 B MX 378402B
Authority
MX
Mexico
Prior art keywords
adapalene
benzoyl peroxide
compositions
topical applications
bpo
Prior art date
Application number
MX2018002176A
Other languages
English (en)
Other versions
MX2018002176A (es
Inventor
Alon Seri-Levy
Karine Neimann
Ofer Toledano
Ori Nov
Original Assignee
Sol Gel Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sol Gel Tech Ltd filed Critical Sol Gel Tech Ltd
Publication of MX2018002176A publication Critical patent/MX2018002176A/es
Publication of MX378402B publication Critical patent/MX378402B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención proporciona composiciones que comprenden como agentes activos peróxido de benzoílo (BPO) y adapaleno, kits y usos de los mismos en métodos para tratar el estado de la superficie de la piel en un sujeto que lo necesite.
MX2018002176A 2015-08-20 2016-08-17 Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno. MX378402B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562207452P 2015-08-20 2015-08-20
PCT/IL2016/050895 WO2017029665A1 (en) 2015-08-20 2016-08-17 Compositions for topical application comprising benzoyl peroxide and adapalene

Publications (2)

Publication Number Publication Date
MX2018002176A MX2018002176A (es) 2018-06-15
MX378402B true MX378402B (es) 2025-03-10

Family

ID=58051282

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018002176A MX378402B (es) 2015-08-20 2016-08-17 Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno.

Country Status (7)

Country Link
US (1) US20180235924A1 (es)
EP (1) EP3337472A4 (es)
JP (2) JP6526322B2 (es)
CN (1) CN108024980A (es)
CA (1) CA2996022C (es)
MX (1) MX378402B (es)
WO (1) WO2017029665A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022542616A (ja) 2019-08-01 2022-10-05 ボシュ ヘルス アイルランド リミテッド 局所組成物
BR112022001300A2 (pt) 2019-08-02 2022-03-22 Nec Corp Dispositivo de processamento de fala, método de processamento de fala, e mídia de gravação
WO2021234716A1 (en) 2020-05-22 2021-11-25 Sol-Gel Technologies Ltd. Stabilized microcapsules, method of their preparation and uses thereof

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4497794A (en) 1980-12-08 1985-02-05 Dermik Laboratories, Inc. Erythromycin/benzoyl peroxide composition for the treatment of acne
US4350681A (en) 1977-10-07 1982-09-21 A.H.C. Pharmacal, Inc. Stabilized benzoyl peroxide compositions
US4361584A (en) 1977-10-07 1982-11-30 A.H.C. Pharmacal, Inc. Composition and method for the treatment of acne
US4235872A (en) 1979-06-04 1980-11-25 E. I. Du Pont De Nemours And Company Microencapsulated methomyl insecticide
US4387107A (en) 1979-07-25 1983-06-07 Dermik Laboratories, Inc. Stable benzoyl peroxide composition
US4670250A (en) 1983-10-21 1987-06-02 Bend Research, Inc. Durable controlled release microcapsules
LU85111A1 (fr) 1983-12-01 1985-09-12 Oreal Composition anti-acnetique a base de peroxyde de benzoyle et d'au moins un filtre solaire
US5086075A (en) 1985-01-24 1992-02-04 Board Of Regents, The University Of Texas System Therapeutic compositions containing benzoyl peroxide
US4690825A (en) 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
US5446028A (en) 1985-12-12 1995-08-29 Dermik Laboratories, Inc. Anti-acne method and composition
US5955109A (en) 1985-12-18 1999-09-21 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of retinoic acid
US5879716A (en) 1985-12-18 1999-03-09 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of benzoyl peroxide
US5145675A (en) 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
EP0248531A3 (en) 1986-05-02 1988-09-28 Southern Research Institute Encapsulated nucleic acids
AT389465B (de) 1987-08-18 1989-12-11 Kwizda Fa F Johann Verfahren zur bildung von mikrokapseln oder mikromatrixkoerpern
FR2628319B1 (fr) 1988-03-09 1990-12-07 Oreal Compositions pharmaceutiques et cosmetiques a base de peroxyde de benzoyle et de sels d'ammonium quaternaires
US4970031A (en) 1988-06-02 1990-11-13 Nok Corporation Process for preparing microcapsules with controlled-release
US5238714A (en) 1990-10-02 1993-08-24 Board Of Regents, The University Of Texas System Efficient microcapsule preparation and method of use
US6117843A (en) 1992-02-18 2000-09-12 Lloyd J. Baroody Compositions for the treatment of acne containing clindamycin and benzoyl peroxide
EP0639048A1 (en) 1992-05-05 1995-02-22 E.I. Du Pont De Nemours And Company Microencapsulation
JP3277342B2 (ja) 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
FR2702375B1 (fr) 1993-03-08 1995-05-05 Virbac Laboratoires Microcapsules à libération progressive, leur procédé de préparation et compositions pharmaceutiques ou vétérinaires les contenant.
US5466446A (en) 1994-02-16 1995-11-14 Stiefel Laboratories, Inc. Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof
US5632996A (en) 1995-04-14 1997-05-27 Imaginative Research Associates, Inc. Benzoyl peroxide and benzoate ester containing compositions suitable for contact with skin
US5851538A (en) 1995-12-29 1998-12-22 Advanced Polymer Systems, Inc. Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
US5998392A (en) 1996-04-10 1999-12-07 Gattefosse S.A. Benzoyl peroxide flocculent materials and methods of their preparation
US6337089B1 (en) 1998-02-06 2002-01-08 Seiwa Kasei Company, Limited Microcapsule containing core material and method for producing the same
DE19810803A1 (de) 1998-03-12 1999-09-16 Wacker Chemie Gmbh Verfahren zur Herstellung mikroverkapselter Produkte mit Organopolysiloxanwänden
US6013637A (en) 1998-06-12 2000-01-11 Dermik Laboratories Inc. Anti-acne method and composition
ES2382536T3 (es) 1998-08-13 2012-06-11 Sol-Gel Technologies Ltd. Procedimiento de preparación de microcápsulas de óxido cargadas con moléculas funcionales y productos obtenidos a partir de las mismas
US6238650B1 (en) 1999-05-26 2001-05-29 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
US6468509B2 (en) 1998-12-18 2002-10-22 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
DE60033279T2 (de) 1999-05-25 2007-11-22 Sol-Gel Technologies Ltd. Ein verfahren zur herstellung von einem lichtstabilen sonnenschutzmittel
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
CA2406008C (en) 2000-04-21 2011-03-15 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
GB2377078B (en) 2001-06-27 2003-06-04 Morgan Crucible Co Fuel cell or electrolyser construction
WO2003039510A1 (en) 2001-11-08 2003-05-15 Sol-Gel Technologies Ltd. Compositions containing oils having a specific gravity higher than the specific gravity of water
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
GB0202853D0 (en) 2002-02-07 2002-03-27 Dow Corning Encapsulation process and encapsulated compositions
AU2003297683A1 (en) 2002-12-13 2004-07-09 Monsanto Technology Llc Microcapsules with amine adjusted release rates
WO2004081222A2 (en) 2003-03-14 2004-09-23 Sol-Gel Technologies Ltd. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
KR100524820B1 (ko) 2003-06-17 2005-10-31 한국화학연구원 실리카 마이크로캡슐의 제조방법
CA2533406C (en) 2003-07-31 2013-01-22 Sol-Gel Technologies Ltd. Microcapsules loaded with active ingredients and a method for their preparation
KR20070027760A (ko) 2004-06-30 2007-03-09 유나이티드 포스포러스 리미티드 농예 활성 물질의 안전한 전달 시스템
GB2416524A (en) 2004-07-24 2006-02-01 Dow Corning Microcapsules with siloxane walls formed in situ
AU2006274541B2 (en) 2005-08-02 2012-12-13 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
WO2007092312A2 (en) * 2006-02-03 2007-08-16 Stiefel Laboratories, Inc. Topical skin treating compositions
US7629394B2 (en) 2006-02-21 2009-12-08 Appleton Papers Inc. UV curable coating material of encapsulated water dispersed core material
FR2903603B1 (fr) * 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
JP5317968B2 (ja) * 2006-07-13 2013-10-16 ガルデルマ・リサーチ・アンド・デヴェロップメント レチノイドと過酸化ベンゾイルとを含む組成物
FR2910321B1 (fr) * 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
HUE025484T2 (en) * 2007-01-30 2016-02-29 Galderma Res & Dev Use of adapalene and benzoyl peroxide for the long term treatment of acne vulgaris
ES2912051T3 (es) * 2007-02-01 2022-05-24 Sol Gel Tech Ltd Composiciones para aplicación tópica que comprenden un peróxido y retinoide
GB0707612D0 (en) 2007-04-19 2007-05-30 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
FR2916975B1 (fr) 2007-06-11 2009-09-04 Galderma Res & Dev Compositions comprenant au moins un compose retinoide, un compose anti-irritant et du peroxyde de benzoyle, et leurs utilisations
WO2009077693A2 (fr) * 2007-11-30 2009-06-25 Galderma Research & Development Compositions comprenant au moins un derive de l'acide naphtoïque, du peroxyde de benzoyle et au moins un agent filmogene, leurs procedes de preparation, et leurs utilisations
RU2490035C2 (ru) * 2008-05-16 2013-08-20 Галдерма Ресерч Энд Девелопмент Схема лечения заболеваний, связанных с акне
WO2011046609A2 (en) 2009-10-15 2011-04-21 Appleton Papers Inc. Encapsulation
KR20130008002A (ko) 2009-12-31 2013-01-21 솔-겔 테크놀로지스 리미티드 코어 안정화 마이크로캡슐, 이의 제조방법 및 이의 용도
US20130131177A1 (en) * 2010-02-09 2013-05-23 Galderma Research & Development Use of a dermatological composition comprising a combination of adapalene and benzoyl peroxide which is intended for the treatment of acne in non-caucasian population with decrease of post-inflammatory hyperpigmentation
EP2726067B1 (en) * 2011-06-29 2020-02-19 Sol-Gel Technologies Ltd. Stabilized topical formulations containing core-shell microcapsules
WO2014028608A1 (en) 2012-08-14 2014-02-20 South Dakota State University Method of treating skin disorders using nanoscale delivery devices and transdermal enhancing compositions
AR092643A1 (es) 2012-09-20 2015-04-29 Procter & Gamble Microcapsulas secadas por aspersion
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
US20140186630A1 (en) 2012-12-27 2014-07-03 Appvion, Inc. Microcapsule Particles
WO2015092602A1 (en) 2013-12-17 2015-06-25 Ranbaxy Laboratories Limited Topical pharmaceutical composition of a retinoid
EP3082785A1 (en) * 2013-12-19 2016-10-26 Galderma Research & Development Therapy regimen for treating severe acne related diseases

Also Published As

Publication number Publication date
JP6526322B2 (ja) 2019-06-05
EP3337472A4 (en) 2019-05-15
EP3337472A1 (en) 2018-06-27
WO2017029665A1 (en) 2017-02-23
CA2996022C (en) 2021-01-05
JP2018523693A (ja) 2018-08-23
JP6788066B2 (ja) 2020-11-18
JP2019142951A (ja) 2019-08-29
US20180235924A1 (en) 2018-08-23
CA2996022A1 (en) 2017-02-23
MX2018002176A (es) 2018-06-15
CN108024980A (zh) 2018-05-11

Similar Documents

Publication Publication Date Title
MX2018005829A (es) Composiciones para tratar el cabello.
DOP2019000180A (es) INHIBIDORES DE TGFß1 ISOFORMA-ESPECÍFICOS CONTEXTO-PERMISIVOS Y USO DE LOS MISMOS
CO2018013557A2 (es) Composiciones que comprenden cepas bacterianas
MX2018005402A (es) Composiciones de tratamiento que proporcionan un beneficio antimicrobiano.
AR096478A1 (es) Composiciones para el tratamiento de superficie que comprenden tintes fotocromáticos
MX379270B (es) Composiciones que comprenden cepas bacterianas.
MX386598B (es) Compuestos antibacterianos.
MX377365B (es) Composiciones y métodos para tratar rosácea y acné.
MX2017009875A (es) Losas procesadas y sistemas y metodos relacionados a las mismas.
MX381290B (es) Formulaciones de peróxido y métodos y aplicaciones para utilizarlas.
UY36357A (es) Composiciones y métodos para la inhibición de la expresión génica de hao1 (hidroxiácido oxidasa 1 (glicolato oxidasa))
ECSP19072372A (es) Moduladores de la expresión de pcsk9
MX2019014772A (es) Formulaciones en gel de bisfosfocinas y usos de estas.
CL2019003670A1 (es) Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta.
EP4609911A3 (en) Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof
CL2017001964A1 (es) Encapsulado de agentes activos de alta potencia.
MX2021010886A (es) Uso de medicamentos para disminuir la evolucion de la enfermedad de parkinson.
CL2015001275A1 (es) Composición gel de lavado a base de bpo.
BR112017019352A2 (pt) composições tópicas comprimidas a corticosteróide aplicações relacionadas
AR102677A1 (es) Composición que comprende sal de acil glutamato como agente tensoactivo primario o agente tensoactivo aniónico primario y polímeros estructurantes específicos
BR112017011685A2 (pt) composições compreendendo 15-hepe e métodos de tratamento ou prevenção da fibrose usando as mesmas
MX378402B (es) Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno.
MX390214B (es) Composicion que comprende agente beneficioso y solvente aprotico.
CL2020000586A1 (es) Moduladores de la expresión de enac.
MX2017014128A (es) 2-tiopirimidinonas.